A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction
Trial details
- Registry ID
- NCT04836182
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ISIS 757456
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection FractionNCT04836182 | IONS | Phase 2 | Completed | 2022-10-19Actual |
| A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood PressureNCT04714320 | IONS | Phase 2 | Completed | 2022-06-29Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |